Validated using a knockout cell line
Recombinant
RabMAb

Anti-CD13 antibody [EPR4058] (ab108310)

Publishing research using ab108310? Please let us know so that we can cite the reference in this datasheet.

ab108310 has been referenced in 5 publications.

  • Harada K  et al. Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors. BMC Cancer 16:548 (2016). PubMed: 27464948
  • Nefla M  et al. The pro-inflammatory cytokine 14-3-3e is a ligand of CD13 in cartilage. J Cell Sci 128:3250-62 (2015). IHC . PubMed: 26208633
  • Vaswani K  et al. The rat placental renin-angiotensin system - a gestational gene expression study. Reprod Biol Endocrinol 13:89 (2015). WB, IHC . PubMed: 26260700
  • Cui SX  et al. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13). Eur J Pharmacol 734:50-9 (2014). PubMed: 24726845
  • Härdtner C  et al. High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic ß-cells. Int J Mol Med 32:795-804 (2013). WB ; Rat . PubMed: 23942780

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up